varicell
vidfarma indÚstria de medicamentos ltda - aesculus hippocastanum l. - antivaricosos de acao sistemica
dermacerium
cristÁlia produtos quÍmicos farmacÊuticos ltda. - sulfadiazina de prata, nitrato de cerio - antinfecciosos topicos-associacoes medicamentosas
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - agentes antitrombóticos - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
bryony
uniÃo quÍmica farmacÊutica nacional s/a - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif
dexperta
blau farmacÊutica s.a. - sugamadex sódico - outros prods nao enquadrados em classe terapeutica especif
lessav
achÉ laboratÓrios farmacÊuticos s.a - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif
reverso
cristÁlia produtos quÍmicos farmacÊuticos ltda. - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif
suversadex
dr. reddys farmacÊutica do brasil ltda - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif
sugamadex sódico
blau farmacÊutica s.a. - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif
instaura
teva farmacÊutica ltda. - sugamadex sÓdico - outros prods nao enquadrados em classe terapeutica especif